An expert panel calls the requirement for tuberculosis testing before prescribing IL-17 and IL-23 biologics for psoriasis an ...

Psoriasis is a chronic, immune-mediated skin condition. It causes red, scaly, itchy, often inflamed patches. Because the ...

Innovent Biologics has picked up approval in China for Pecondle, its anti-IL-23p19 antibody, as a treatment for ...

The blogger Howard Chang explores the latest advancements bringing hope for a psoriasis cure, some of which were presented at a community event.

Despite challenges such as high costs and access barriers, the demand for effective, tailored therapies continues to rise, transforming the psoriasis treatment landscapeDublin, Nov. 26, 2025 (GLOBE ...

Innovent Biologics ( ($HK:1801) ) has provided an announcement. Innovent Biologics has announced that its new drug, PECONDLE® (picankibart ...

Treatment with envudeucitinib was safe and effective through 52 weeks among patients with with moderate to severe plaque psoriasis.

Prescription Drug User Fee Act (PDUFA) target action date set for June 29, 2026If approved, ZORYVE cream 0.3% would be the first and only topical ...

TREMFYA® (guselkumab) is now clinically proven to protect joints in active psoriatic arthritis, offering durable efficacy and ...

Biologic therapy use among patients with psoriatic disease was associated with a lower risk for malignancy compared with topical therapy use.

FOR Dar es Salaam resident Frank Latamani, the chronic skin condition known as Psoriasis has become not only a painful ordeal ...

China: Researchers have found in a new study that secukinumab and ixekizumab demonstrate comparable clinical efficacy for ...